Holen Sie sich die Stockscreener-App
5.37
6.76%
0.34
Handel nachbörslich:
5.36
-0.010
-0.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Cost Of Revenue |
-
|
- | - | - | - |
| Selling, General, and Administrative |
4.50%
2.867
|
3.002 | 2.858 | 2.481 | 2.967 |
| Costs And Expenses |
3.06%
7.083
|
6.873 | 6.063 | 6.918 | 7.329 |
| Operating Income/Loss |
3.06%
-7.083
|
-6.873 | -6.063 | -6.918 | -7.329 |
| Nonoperating Income/Loss |
7.35%
0.292
|
0.272 | 0.25 | 0.181 | 0.221 |
| Income/Loss From Continuing Operations Before Tax |
3.06%
-7.083
|
-6.873 | -6.063 | -6.286 | -7.329 |
| Income/Loss From Continuing Operations After Tax |
2.88%
-6.791
|
-6.601 | -5.813 | -6.737 | -7.108 |
Net Income/Loss
|
2.88%
-6.791
|
-6.601 | -5.813 | -6.737 | -7.108 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.98%
108.40
|
98.56 | 87.76 | 4.2618 | 68.25 |
| Diluted Average Shares |
9.98%
108.40
|
98.56 | 87.76 | 4.2618 | 68.25 |
| Basic Earnings Per Share |
14.29%
-0.06
|
-0.07 | -0.07 | -0.08 | -0.10 |
| Diluted Earnings Per Share |
14.29%
-0.06
|
-0.07 | -0.07 | -0.08 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):